Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL9SN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on December 2, 2025, with an ultimate completion date of December 23, 2025. The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support platform for military healthcare programs.
The delivery order supplies Vyndamax, a prescription medication used primarily for treating transthyretin cardiac amyloidosis, to support the military healthcare supply chain. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, delivering a diverse range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The firm fixed-price structure and relatively short delivery window reflect the urgent nature of military pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FL9SN?
SPE2DR26FL9SN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FL9SN worth?
The government has obligated $14,593 on SPE2DR26FL9SN.
Is contract SPE2DR26FL9SN an order under another contract?
Yes. SPE2DR26FL9SN is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9SN competed?
The extent of competition for SPE2DR26FL9SN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award